Skip to content

Drug interactions

Infliximab + Ocrelizumab

Severity: Moderate

Infliximab and Ocrelizumab: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ocrelizumab depletes CD20-positive B cells while infliximab blocks TNF-alpha. Using both may increase the likelihood of serious or opportunistic infections.

What this interaction means in plain words

Infliximab and Ocrelizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Infliximab belongs to Musculoskeletal; Ocrelizumab belongs to Central Nervous System.

Evidence level: Low

Why it happens

Additive immunosuppression through B-cell depletion and TNF inhibition.

What to do

Avoid combining unless clearly needed, and screen for active infection before dosing. Monitor for infection throughout treatment and for months after ocrelizumab, since B-cell depletion persists.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Infliximab and Ocrelizumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Infliximab with Ocrelizumab?

MediHelp rates the interaction as moderate. Infliximab and Ocrelizumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ocrelizumab depletes CD20-positive B cells while infliximab blocks TNF-alpha. Using both may increase the likelihood of serious or opportunistic infections.

How serious is the interaction between Infliximab and Ocrelizumab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid combining unless clearly needed, and screen for active infection before dosing. Monitor for infection throughout treatment and for months after ocrelizumab, since B-cell depletion persists.

What other medicines interact with Infliximab?

MediHelp also lists interactions of Infliximab with, for example, Bcg vaccine live, Influenza virus vaccine quadrivalent intranasal, Measles mumps and rubella vaccine. The full list is on the Infliximab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in